December 12, 2016
2017 International Conference on Alzheimer’s Disease and Parkinson’s Disease
APRINOIA will be presenting the first-in-the-human clinical trial result for its lead Tau PET Imaging Tracer APN-1607 (PM-PBB3) at the 13th International Conference on Alzheimer's Disease and Parkinson's Disease (AD&PD) in Vienna in March 2017.
December 5, 2016
Hosts 2016 Taiwan Neuroscience Conference
APRINOIA is proud to host 2016 Taiwan Neuroscience Conference with Development Center for Biotechnology (DCB) and Academia Sinica on the 5th December 2016.
November 20, 2016
US FDA Approved APRINOIA Conduct Clinical Trial
APRINOIA has received written approval from the US FDA to conduct the first-in-the-human clinical trial in the US.